Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment

NCT00688376 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Impairment

Interventions

DRUG: Donepezil hydrochloride
DRUG: Placebo

Sponsor

Eisai Inc.

Collaborators

[object Object]